Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Neovasc Inc (NVCN.TO)

Neovasc Inc (NVCN.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 111,760
  • Shares Outstanding, K 2,759
  • Annual Sales, $ 2,547 K
  • Annual Income, $ -24,889 K
  • 60-Month Beta 1.82
  • Price/Sales 21.51
  • Price/Cash Flow N/A
  • Price/Book 5.22
Trade NVCN.TO with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -15.07
  • Most Recent Earnings $-5.04 on N/A
  • Latest Earnings Date 05/11/23
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/23
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -3.81
  • Growth Rate Est. (year over year) +26,320.47%

Price Performance

See More
Period Period Low Period High Performance
1-Month
39.28 +2.21%
on 03/30/23
40.83 -1.67%
on 03/24/23
-0.49 (-1.21%)
since 03/10/23
3-Month
24.92 +61.12%
on 01/11/23
41.20 -2.55%
on 03/09/23
+15.35 (+61.90%)
since 01/10/23
52-Week
6.00 +569.17%
on 06/17/22
41.20 -2.55%
on 03/09/23
+27.15 (+208.85%)
since 04/08/22

Most Recent Stories

More News
Shockwave Medical Completes Acquisition of Neovasc

Santa Clara, California--(Newsfile Corp. - April 11, 2023) - Shockwave Medical, Inc. (NASDAQ: SWAV) ("Shockwave"), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified...

NVCN.TO : 40.15 (+0.58%)
SWAV : 328.54 (-0.02%)
NVCN : 30.03 (+1.66%)
Neovasc: Q4 Earnings Snapshot

Neovasc: Q4 Earnings Snapshot

NVCN.TO : 40.15 (+0.58%)
Neovasc Shareholders Approve Acquisition by Shockwave Medical

Vancouver, British Columbia--(Newsfile Corp. - March 6, 2023) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company"), a leader in the development of minimally invasive devices for the treatment...

NVCN.TO : 40.15 (+0.58%)
NVCN : 30.03 (+1.66%)
Neovasc Announces German Reimbursement Renewal

Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - February 1, 2023) - Neovasc, Inc. (NASDAQ : NVCN) (TSX : NVCN) ("Neovasc" or "the Company") today announced the German Institute...

NVCN.TO : 40.15 (+0.58%)
NVCN : 30.03 (+1.66%)
Neovasc (NASDAQ: NVCN) (TSX: NVCN) Enters into Agreement to be Acquired by Shockwave Medical (NASDAQ: SWAV) for $100 Million & CVR

Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) is engaged as a specialty medical device company, which is focused on the development,

NVCN : 30.03 (+1.66%)
NVCN.TO : 40.15 (+0.58%)
SWAV : 328.54 (-0.02%)
Shockwave Medical to Acquire Neovasc

Vancouver, British Columbia--(Newsfile Corp. - January 17, 2023) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company"), a leader in the development of minimally invasive devices for the...

NVCN.TO : 40.15 (+0.58%)
NVCN : 30.03 (+1.66%)
Neovasc: Q3 Earnings Snapshot

Neovasc: Q3 Earnings Snapshot

NVCN.TO : 40.15 (+0.58%)
Neovasc to Report Second Quarter Financial Results on August 11, 2022

VANCOUVER and MINNEAPOLIS, July 28, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. (NASDAQ ,  TSX : NVCN), will report financial results for...

NVCN : 30.03 (+1.66%)
NVCN.TO : 40.15 (+0.58%)
Neovasc Announces FDA Approval of Planned COSIRA II Sub-studies and Single Arm Registry to Allow Inclusion of Additional Specified Patient Populations

VANCOUVER and MINNEAPOLIS, July 26, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) today...

NVCN : 30.03 (+1.66%)
NVCN.TO : 40.15 (+0.58%)
Stocks in play: Neovasc Inc

Today announced that the company has expanded its direct sales operations in Europe to include the United ...

NVCN.TO : 40.15 (+0.58%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Neovasc Inc is a specialty medical device company. It develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products the Neovasc Reducer (Reducer), for the treatment of refractory angina, which is not currently commercially available in the United States...

See More

Key Turning Points

3rd Resistance Point 40.50
2nd Resistance Point 40.32
1st Resistance Point 40.24
Last Price 40.15
1st Support Level 39.98
2nd Support Level 39.80
3rd Support Level 39.72

See More

52-Week High 41.20
Last Price 40.15
Fibonacci 61.8% 27.75
Fibonacci 50% 23.60
Fibonacci 38.2% 19.45
52-Week Low 6.00

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar